Boston, USA - The 2025 BIO International Convention (hereinafter referred to as the "BIO Conference") was grandly held at the Boston Convention & Exhibition Center from June 16th to 19th, 2025. Founded in 1993 and hosted by the Biotechnology Innovation Organization (BIO), the BIO Conference is one of the world's largest and most influential gatherings in the biotechnology industry. It attracts leading biopharmaceutical companies, investors, and partners from around the globe every year.

The conference brought together over 20,000 attendees from across the global industry. Through four days of dynamic exchanges and interactions, participants shared scientific research achievements and explored new development opportunities together.

Dr. Liu Xun, CEO of Taichu Group, led the company's team to Boston to attend this year's BIO Conference. The team joined top scientists and corporate representatives from the global biopharmaceutical field for in-depth discussions focused on integrated CRO+CDMO services. Taichu shared its experience and capabilities in innovative drug services while exploring international collaboration opportunities, aiming to jointly advance global innovation development and commercialization processes.

On the afternoon of June 16th (local time), Dr. Liu Xun delivered a presentation in the exhibition area, introducing Taichu Group's business layout and the latest research achievements in AOC conjugate drug development to the attending guests. This garnered significant attention, leading to further in-depth exchanges at the Taichu booth following the presentation.

Throughout the conference, Taichu Group shared its extensive R&D experience and comprehensive service capabilities with global biopharmaceutical researchers. The areas covered included:Pre-Clinical Research，Antibody Discovery and Design，Biologics  Development and Manufacturing，Nucleic Acid Drug Process Development  and  GMP Manufacturing.

Taichu Group will continue to uphold its core values of " Advocate of Ethics and Integrity, Quest for Verity" to support global drug R&D companies in their project development. Taichu Group will also maintain a close watch on international market demands, further enhancing its service capabilities and expanding its business scope while strengthening its efforts in international market development. At the same time, we sincerely invite clients and peers from around the world to visit the Taichu Group headquarters located in Lingang, Shanghai, China, for tours and exchanges.